Use of arctigenin in the preparation of medicines for treating systemic lupus erythematosus

A technology of arctigenin and lupus erythematosus, which is applied in the field of medicine and can solve problems such as the use of arctigenin in lupus erythematosus that has not been reported, and achieve the effects of correcting abnormal immune function, reducing the content, and acting quickly

Active Publication Date: 2016-03-02
LUNAN PHARMA GROUP CORPORATION
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

It has been proved that arctigenin has stronger biological activity than arctiin, such as significant antibacterial, antiviral, antitumor, anti-PAF receptor and calcium antagonistic activities, but arctigenin has not been reported in the prior art Use in the preparation of medicines for treating systemic lupus erythematosus

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Use of arctigenin in the preparation of medicines for treating systemic lupus erythematosus
  • Use of arctigenin in the preparation of medicines for treating systemic lupus erythematosus
  • Use of arctigenin in the preparation of medicines for treating systemic lupus erythematosus

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0019] Embodiment 1 arctigenin injection

[0020] prescription:

[0021] Arctigenin 4g

[0022] PEG-400200ml

[0023] Add 0.9% sodium chloride solution to 1000ml

[0024] Preparation Process:

[0025] Add the prescribed amount of PEG-400 to arctigenin, stir to dissolve, add the prescribed amount of 0.9% sodium chloride solution to 1000ml, stir evenly, adjust the pH to 3, add 0.5% activated carbon for needles, stir, and decarbonize, that is have to.

Embodiment 2

[0026] Embodiment 2 arctigenin injection

[0027] prescription:

[0028] Arctigenin 5g

[0029] PEG-300300ml

[0030] Add 0.9% sodium chloride solution to 1000ml

[0031] Preparation Process:

[0032] Add the prescribed amount of PEG-300 to arctigenin, stir to dissolve, add 0.9% sodium chloride solution to 1000ml, stir evenly, adjust the pH to 4, add 0.5% activated carbon for needles, stir, decarbonize, and the product is ready. Embodiment 3 arctigenin injection

Embodiment 3

[0032] Add the prescribed amount of PEG-300 to arctigenin, stir to dissolve, add 0.9% sodium chloride solution to 1000ml, stir evenly, adjust the pH to 4, add 0.5% activated carbon for needles, stir, decarbonize, and the product is ready. Embodiment 3 arctigenin injection

[0033] prescription:

[0034] Arctigenin 4g

[0035] PEG-400100ml

[0036] Add water for injection to 1000ml

[0037] Preparation Process:

[0038] Add the prescribed amount of PEG-400 to arctigenin, stir to dissolve, add water for injection to 1000ml, stir evenly, adjust the pH to 5 with citric acid, add 0.5% activated carbon for needles, stir, decarbonize, and the product is ready.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention belongs to medicine field, and specifically relates to an application of arctigenin to preparing medicaments for treating systemic lupus erythematosus (SLE). Arctigenin is capable of effectively lymphocyte dysfunction of SLE mise and secretion unbalance of multiple cytokines, has substantial treatment effect on systemic lupus erythematosus, and has the potential of being exploited into the medicaments for treating systemic lupus erythematosus.

Description

technical field [0001] The invention belongs to the field of medicine, and in particular relates to the use of arctigenin in the preparation of medicines for treating systemic lupus erythematosus. Background technique [0002] Systemic lupus erythematosus (systemic lupus erythematosus; SLE) is a diffuse, systemic autoimmune disease, mainly involving the skin and mucous membranes, skeletal muscles, kidneys and central nervous system, and may also involve lungs, heart, blood and other organs and systems , showing a variety of clinical manifestations, the etiology and pathogenesis are not yet clear, a variety of autoantibodies and immunological abnormalities can be detected in the serum of patients with systemic lupus erythematosus, abnormal lymphocyte function and a variety of cytokine secretion imbalance in the disease Studies have confirmed that CD3+CD4+T cells in the peripheral blood of patients with systemic lupus erythematosus decreased, CD3+CD8+T cells increased, and the...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/365A61P19/04A61P37/02
Inventor 赵志全徐真真李斌
Owner LUNAN PHARMA GROUP CORPORATION
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap